Publications
- Elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis ineligible for clinical trials: a 24-week observational study2023 | Second Faculty of Medicine
- Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-192020 | Second Faculty of Medicine, First Faculty of Medicine
- Ivacaftor in adults with cystic fibrosis: a ten-year follow-pu of lung function and nutritional sttus2020 | Second Faculty of Medicine
- Ivacaftor in cystic fibrosis adults: Czech experience with six years of follow-up2016 | Second Faculty of Medicine
- Factors affecting survival in cystic fibrosis: a ten-year study2015 | Second Faculty of Medicine
- Extracorporeal membrane oxygenation to support repeated whole-lung lavage in a patient with pulmonary alveolar proteinosis in life threatening dyspnoe - a case report2015 | Second Faculty of Medicine
- Lung cancer, pulmonary emphysema and pleural effusion: An autopsy study2015 | Second Faculty of Medicine
- Oxidative stress in cystic fibrosis patients with Burkholderia cenocepacia airway colonization: relation of 8-isoprostane concentration in exhaled breath condensate to lung function decline2014 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Pulmonary arterial hypertension in cystic fibrosis: a study in adult lung transplant candidates2014 | Second Faculty of Medicine
- Pulmonary alveolar proteinosis: Whole-lung lavage with the support of extracorporeal membrane oxygenation2013 | Second Faculty of Medicine
Loading network view...